A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic
Feb 24 (Reuters) – The European Union's health regulator on Thursday backed giving a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine to adolescents aged 12 and over, as well as the expanded use of Moderna's (MRNA.O) shot in children ages six to 11.
The recommendations by the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use will be followed by final decisions by the European Commission.
The moves come after several EU countries already started to offer booster doses of the Pfizer/BioNTech vaccine to teens.
Germany's vaccine committee in January recommended all children between the ages of 12 and 17 receive a booster, following the initial two-shot course. Other nations in the region followed suit.
The European Centre for Disease Prevention and Control (ECDC) said in a report this month that 10 countries in the European Economic Area, which comprises the 27 EU member states plus Liechtenstein, Iceland and Norway, had already recommended a booster dose for those under 18 years of age.
Member States' decision on whether and when to offer boosters in this age group will need to take into account factors such as the spread and likely severity of the disease in younger persons and the known risk of side effects like the rare heart complication myocarditis, the EMA said.
The agency on Thursday also recommended approval of Moderna's COVID vaccine for use in children aged 6 to 11.
Moderna's Spikevax COVID shot is already approved for use in adults and children aged 12 and over in Europe.
In the United States, the Moderna vaccine is authorized as a primary two-dose regimen and booster dose for adults 18 years and older. The company has yet to win clearance for use in younger age groups. read more
The dose of Spikevax in 6- to 11-year-olds will be 50 micrograms instead of the 100 micrograms used for people aged 12 and over, the EMA said.
Our Standards: The Thomson Reuters Trust Principles.
Sign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.
Subscribe to our newsletter to get all the news you need to start your day.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved

source